Beauty Tech Execs Sell £6M After Strong IPO

Noah Miller 10/13/2026

The beauty technology landscape is clearly heating up, and the high-flying shares of Beauty Tech Group reflected this surging demand perfectly. Following a stellar run since its London Stock Exchange listing in October 2025, Chief Executive Laurence Newman and Chief Technology Officer Andrew Showman recently realized a combined £6 million from their shareholdings.

This significant transaction underscores the market’s continued appetite for innovative at-home beauty solutions. The company, based in Cheshire, has successfully positioned itself at the intersection of cosmetics, dermatology, and consumer technology, boasting a valuation of approximately £300 million.

Beauty Tech Group’s impressive portfolio is packed with cutting-edge devices, including CurrentBody Skin, ZIIP Beauty, and Tria Laser. These products span sophisticated LED skincare masks and advanced laser hair removal devices, demonstrating a commitment to high-tech, tangible beauty results.

The momentum behind the company is not just driven by its product range; it is fueled by robust financial performance. The company experienced powerful growth, with first-half 2026 revenue soaring by 44.3 percent to reach £79.7 million. This strong trading performance has made the share price climb substantially, signaling strong investor confidence in the company’s trajectory.

Beyond immediate growth, the leadership is actively pushing the boundaries of what is possible in the beauty space. A key focus is integrating artificial intelligence into their research and development. Beauty Tech Group is actively collaborating with the University of Manchester’s School of Dermatology to explore AI applications in skin and hair analysis, opening doors for deeper clinical research.

This focus on AI-supported innovation reflects a broader trend: the convergence of advanced cosmetics, clinical dermatology, and consumer technology. It shows that the future of beauty is not just about devices, but about smart, data-driven solutions that offer unparalleled analysis and personalized care.